The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I open-label single arm study of GPRC5D CAR T-cells (OriCAR-017) in patients with relapsed/refractory multiple myeloma (POLARIS).
 
He Huang
No Relationships to Disclose
 
Yongxian Hu
No Relationships to Disclose
 
Mingming Zhang
No Relationships to Disclose
 
Xiaomin Ding
No Relationships to Disclose
 
Yu Tang
No Relationships to Disclose
 
Xiaowen He
Employment - Origincell Therapeutics
Leadership - Origincell Therapeutics
Research Funding - Origincell Therapeutics
Patents, Royalties, Other Intellectual Property - I have a patent pending related to the technology used in the abstract.
 
Siye Chen
No Relationships to Disclose
 
Yue Yang
No Relationships to Disclose